Skip to main content
letter
. 2014 Jan 17;28(5):1152–1154. doi: 10.1038/leu.2013.382

Figure 1.

Figure 1

JAK2, MPL and CALR mutation frequency in patients with persistent thrombocytosis and associated hematological parameters. (a) Incidence of JAK2 V617F, MPL W515L/K and CALR exon 9 mutations in 289 patients investigated for thrombocytosis. (b) White blood cell (WBC), hemoglobin (Hb), platelet (PLT) and red blood cell (RBC) counts in the four patient groups studied (*P<0.05, **P<0.01, ****P<0.0001 by one-way analysis of variance with Tukey's multiple testing correction).